QualityStocksNewsBreaks Archives - Page 574 of 1482

FridayDec 10, 2021 1:28 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Expanding Market Reach

StraightUp Resources (CSE: ST) (OTCQB: STUPF), at the beginning of the year, broke down its 2021 exploration program into four elements: historical data review, compilation and interpretation; examining historical drill core (“ENDM” core library, Red Lake); geological mapping and sampling; and geophysical surveys. “The objective was to add new 2021 data to enhance interpretations, locate prime locations for drilling holes and conduct soil sampling to inform the company’s investment decisions and guarantee a return on its investment,” reads a recent article. “So far, these efforts have allowed StraightUp to acquire prime properties with tremendous potential to maximize shareholder wealth. It…

FridayDec 10, 2021 12:37 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Positioned Favorably within Rapidly Growing iGaming Industry

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) is positioned to take a significant share of the growing online gambling market by offering a first-rate experience while ensuring total user privacy. Analysts at Research and Markets expect this space to grow at a CAGR of 11.94% between 2021 and 2026, while Grand View Research projects that it will reach $127.3 billion by 2027, with much of that growth coming from the United States and Asia. “PLGNF provides an innovative multitenant gateway that enables online operators to offer users popular games… The company’s proprietary software combines high-definition live streaming dealers with…

FridayDec 10, 2021 12:22 pm

QualityStocksNewsBreaks – Mind Medicine (‘MindMed’) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) Engages with FDA for Development of the ‘MSMS’

Mind Medicine (“MindMed”) (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, recently met with the United States Food and Drug Administration (“FDA”) Center for Devices and Radiological Health (“CDRH”) with consultation from the Center for Drug Evaluation and Research (“CDER”). The device pre-submission meeting that took place on Oct. 25, 2021, was concerning several key points for ongoing development of the MindMed Session Monitoring System (“MSMS”). MindMed presented the FDA with a working Indications for Use (“IFU”) statement and a development roadmap, which describe technology and infrastructure for the collection of precise, multimodal, multivalent data…

FridayDec 10, 2021 11:31 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Replays Available from Sequire Clean Tech Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has made available key presentations from its Sequire Clean Tech & Electric Vehicles Conference. The premier virtual investor event was held on Dec. 6, 2021, and featured presentations from more than 25 elite stock market companies that are leading the way in the clean-tech space; the event also included insightful addresses and discussions with industry execs looking at the future of clean tech. Topics covered electric vehicles, energy and power, and materials and chemicals. Replays of the keynote…

FridayDec 10, 2021 11:10 am

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Publication of Technical Paper on Biophysics-Based CDA Cancer Detection Technology

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that its joint technical paper on novel Cancer Differentiation Analysis (“CDA”) Technology for multi-cancer screening with multiple leading medical institutions was accepted and published online. The piece was published on Nov. 30 by the Expert Review of Molecular Diagnostics, a peer-reviewed international medical journal that has an impact factor of 5.2. “We are very pleased with the publication of our technical paper on CDA cancer detection technology by a peer-reviewed international journal in the field of medicine,” said Dr. Chris Yu, AnPac Bio’s…

FridayDec 10, 2021 10:30 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Upcoming Investor Call

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) CEO and other key leaders will be hosting a year-end update call. The call, which will be held on Dec. 15, 2021, at 1 p.m. ET, will also include a discussion about the company’s growth strategy looking forward. According to the company, the one-hour call will include opening remarks, and overview presentation and update, and a Q&A session. Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. “We’ve had our best year yet, despite many external factors that created headwinds, and we’re extremely excited to head…

ThursdayDec 09, 2021 2:43 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Financing to Provide Runway for Key Milestones

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into an agreement with an investor to complete a non-brokered private placement (the “financing”) of a convertible secured subordinated debenture in the principal amount of C$5.5 million. According to the update, the financing is expected to close on Dec. 10, 2021. “I would like to thank our incredible strategic shareholder for stepping up in a tough, volatile market and continuing to support and expand upon your large stake in Mydecine,” said the…

ThursdayDec 09, 2021 2:27 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol as Therapeutic Option for Disease Treatment

InMed Pharmaceuticals (NASDAQ: INM) recently released its Q1 2022 financial results along with a business update showing positive momentum across all of its programs. Following the acquisition of BayMedica Inc. in October that created an industry leader in the manufacture and commercialization of rare cannabinoids, management expects to introduce multiple new, rare cannabinoids in the near future, focusing on high demand, attractive margin products. In late September, InMed commenced the 755-201-EB study, its phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders scientifically known as Epidermolysis Bullosa (“EB”). A recent article…

ThursdayDec 09, 2021 1:59 pm

QualityStocksNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) AI Solution Helping Employers Identify Right Talent, Users Identify Personality Traits

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is poised to benefit from the fact that AI technology may just be what companies need to make decisions on hiring the right talent and personality for a job. DIGI’s Projected Personality Interpreter (“PPI”), which was originally conceived and launched by Darwin Ecosystems, a company that was acquired by DigiMax late last year, evaluates a company’s workforce, brand and culture by revealing the personality traits and sentiments buried in human expression. “By leveraging IBM Watson and a customer algorithm that analyzes applicant responses across…

ThursdayDec 09, 2021 12:56 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a…

Site Search

Company Search

Category: QualityStocksNewsBreaks